摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(3-{[4-(1-methyl-1,2,5,6-tetrahydropyridin-3-yl)-1,2,5-thiadiazol-3-yl]oxy}propyl)-N'-(1,2,3,4-tetrahydroacridin-9-yl)octane-1,8-diamine | 1214274-40-4

中文名称
——
中文别名
——
英文名称
N-(3-{[4-(1-methyl-1,2,5,6-tetrahydropyridin-3-yl)-1,2,5-thiadiazol-3-yl]oxy}propyl)-N'-(1,2,3,4-tetrahydroacridin-9-yl)octane-1,8-diamine
英文别名
N-[3-[[4-(1-methyl-3,6-dihydro-2H-pyridin-5-yl)-1,2,5-thiadiazol-3-yl]oxy]propyl]-N'-(1,2,3,4-tetrahydroacridin-9-yl)octane-1,8-diamine
N-(3-{[4-(1-methyl-1,2,5,6-tetrahydropyridin-3-yl)-1,2,5-thiadiazol-3-yl]oxy}propyl)-N'-(1,2,3,4-tetrahydroacridin-9-yl)octane-1,8-diamine化学式
CAS
1214274-40-4
化学式
C32H46N6OS
mdl
——
分子量
562.823
InChiKey
IIPLCOXQFRPWPZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.5
  • 重原子数:
    40
  • 可旋转键数:
    16
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.59
  • 拓扑面积:
    103
  • 氢给体数:
    2
  • 氢受体数:
    8

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    5-[4-(3-bromopropoxy)-1,2,5-thiadiazol-3-yl]-1-methyl-1,2,3,6-tetrahydropyridineN-(1,2,3,4-tetrahydroacridin-9-yl)octane-1,8-diaminepotassium carbonate 、 potassium iodide 作用下, 以 二氯甲烷 为溶剂, 反应 18.0h, 以34%的产率得到N-(3-{[4-(1-methyl-1,2,5,6-tetrahydropyridin-3-yl)-1,2,5-thiadiazol-3-yl]oxy}propyl)-N'-(1,2,3,4-tetrahydroacridin-9-yl)octane-1,8-diamine
    参考文献:
    名称:
    Hybrid Molecules from Xanomeline and Tacrine: Enhanced Tacrine Actions on Cholinesterases and Muscarinic M1 Receptors
    摘要:
    A set of amide- and amine-linked hybrid molecules comprising moieties of the orthosteric M-1 muscarinic receptor agonist xanomeline and the cholinesterase inhibitor and allosteric receptor modulator tacrine were prepared with varying spacer length of 10-17 atoms. The hybrids inhibited acetylcholinesterase with similar or higher potency compared to tacrine. M, receptor binding affinity was similar or higher relative to xanomeline and far higher relative to tacrine. Affinities hardly changed when the receptors' orthosteric site was Occupied by all inverse agonist ligand. When Occupied by the orthosteric activator acetylcholine, affinity for the hybrids declined to unmeasureably low levels. Hybrids did not activate M-1 receptors. In vivo studies assaying cognition impairment in rats induced by scopolamine revealed pronounced enhancement of scopolamine action. Taken together, instead of dualsteric (simultaneous allosteric/orthosteric) binding, the hybrids seem to prefer purely allosteric binding at the inactive M-1 receptor.
    DOI:
    10.1021/jm901616h
点击查看最新优质反应信息

文献信息

  • Hybrid Molecules from Xanomeline and Tacrine: Enhanced Tacrine Actions on Cholinesterases and Muscarinic M<sub>1</sub> Receptors
    作者:Lei Fang、Sabine Jumpertz、Yihua Zhang、Dorothea Appenroth、Christian Fleck、Klaus Mohr、Christian Tränkle、Michael Decker
    DOI:10.1021/jm901616h
    日期:2010.3.11
    A set of amide- and amine-linked hybrid molecules comprising moieties of the orthosteric M-1 muscarinic receptor agonist xanomeline and the cholinesterase inhibitor and allosteric receptor modulator tacrine were prepared with varying spacer length of 10-17 atoms. The hybrids inhibited acetylcholinesterase with similar or higher potency compared to tacrine. M, receptor binding affinity was similar or higher relative to xanomeline and far higher relative to tacrine. Affinities hardly changed when the receptors' orthosteric site was Occupied by all inverse agonist ligand. When Occupied by the orthosteric activator acetylcholine, affinity for the hybrids declined to unmeasureably low levels. Hybrids did not activate M-1 receptors. In vivo studies assaying cognition impairment in rats induced by scopolamine revealed pronounced enhancement of scopolamine action. Taken together, instead of dualsteric (simultaneous allosteric/orthosteric) binding, the hybrids seem to prefer purely allosteric binding at the inactive M-1 receptor.
查看更多